Working… Menu
Trial record 1 of 1 for:    Nativis 109
Previous Study | Return to List | Next Study

Nativis Voyager for Newly Diagnosed GBM (NAT109)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03276286
Recruitment Status : Unknown
Verified August 2019 by Nativis, Inc..
Recruitment status was:  Active, not recruiting
First Posted : September 8, 2017
Last Update Posted : August 20, 2019
Information provided by (Responsible Party):
Nativis, Inc.

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : January 31, 2020
Estimated Study Completion Date : January 31, 2020